pharma · IgA Nephropathy · Rhematoid Arthritis · JBIO
Jade Biosciences
Jade Biosciences clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Waltham, USA HQ
2024 Founded
72 Employees
Public company Type
JBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2024
- Employees
- 72
- Programs
- 4
- Drugs
- 1
- Patents
- 2
Jade Biosciences projects
0 ClinicalTrials.gov programs sponsored by Jade Biosciences.
Jade Biosciences has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Jade Biosciences have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.